Right treatment. Right time. Right outcome.
TheraMind turns deep biological and clinical intelligence into coordinated, proactive care — orchestrating the whole journey, and putting an AI co-pilot beside every physician.
Intelligence is only useful when it reaches care.
TheraMind applies intelligence to care orchestration — across the health system, in the consulting room, at the point of prescription, and after the dose is given. It reads the eleven-layer Digital Twin rather than holding a model of its own, and is driven by the Care and Clinical agent families in MSI CORE™.
Care orchestration
Coordinates personalised, proactive care across the whole continuum — from prevention to recovery.
The care journey →Point of care · GP Co-PilotAI-augmented GP
Real-time clinical decision support, evidence-based recommendation and automated documentation.
The co-pilot →At prescriptionPharmacogenomics
Genotype-driven dosing surfaced before the prescription is written. Tested once, used for life.
PGx →After the dosePharmacovigilance
Structured adverse event capture, causality assessment, statutory reporting and stratified signal detection.
PV →Care today is reactive, fragmented and late.
Systems act after symptoms appear, on disconnected data — and the physicians holding it together are overloaded.
We have removed the quantified versions of these statements. They circulate widely but we could not trace each to a primary source we were willing to stand behind, and an unsourced figure on a clinical platform is worse than no figure.
The whole continuum, orchestrated.
One seamless, intelligent journey that delivers the right care, at the right time, to the right patient — and never stops improving.
Model risk and progression to prevent disease and detect it early.
Integrate multi-omics, imaging and clinical data for accurate diagnosis.
Personalised treatment plans matched to each patient’s profile — including genotype-driven dosing.
Continuous monitoring with early alerts, adverse-event capture and timely adjustment.
Outcomes feed back into the evidence base, sharpening every subsequent recommendation.
Prospective signal, retrospective signal.
Pharmacogenomics predicts who will respond badly before the dose. Pharmacovigilance captures what actually happened after it. Together they close a loop few organisations are positioned to close.
Available at every prescribing event for the rest of a patient’s life.
Prospective — dosing risk surfaced before the drug is given.
Adverse events, response and non-response, in a defined vocabulary.
By genotype and metabolic phenotype across the twin population.
Which changes the guidance offered at the next prescription.
Better for everyone in the room.
Patient-centric
Personalised care that improves lives.
Clinician-empowered
Actionable insight for better decisions.
System-efficient
Streamlined workflows, lower cost.
Outcome-driven
Measurable impact on health and spend.
Trusted & secure
Enterprise-grade security, residency where required.
Bring intelligent care to your patients.
For health systems evaluating care orchestration, or clinics that want the GP co-pilot — let us find the right starting point.